首页> 美国卫生研究院文献>BMC Cancer >Efficacy and safety of concurrent anti-Cancer and anti-tuberculosis chemotherapy in Cancer patients with active Mycobacterium tuberculosis: a retrospective study

【2h】

Efficacy and safety of concurrent anti-Cancer and anti-tuberculosis chemotherapy in Cancer patients with active Mycobacterium tuberculosis: a retrospective study

机译：癌症患者活动性结核分枝杆菌同时抗癌和抗结核化疗的疗效和安全性：一项回顾性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundIn our previous study, colorectal cancer (CRC) patients with active Mycobacterium tuberculosis (MTB) tolerated concurrent anti-cancer chemotherapy (anti-CCT) and anti-MTB chemotherapy. In this study, we retrospectively confirmed the efficacy and safety of concurrent chemotherapy in a greater number of patients with different types of malignancies.

机译：背景在我们先前的研究中，患有活动性结核分枝杆菌（MTB）的结直肠癌（CRC）患者耐受同时抗癌化疗（anti-CCT）和抗MTB化疗。在这项研究中，我们回顾性地证实了同时化疗在更多类型不同恶性肿瘤患者中的有效性和安全性。

著录项

期刊名称 BMC Cancer
作者
Tomonori Hirashima; Yoshitaka Tamura; Yuki Han; Shoji Hashimoto; Ayako Tanaka; Takayuki Shiroyama; Naoko Morishita; Hidekazu Suzuki; Norio Okamoto; Shinobu Akada; Makoto Fujishima; Yoshihisa Kadota; Kazuya Sakata; Akiko Nishitani; Satoru Miyazaki; Takayuki Nagai;
展开▼
作者单位

展开▼
年(卷),期 2018(18),-1
年度 2018
页码 975
总页数 10
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
Concurrent chemotherapy Tuberculosis Breast cancer Colorectal cancer Efficacy Gastric cancer Lung cancer Safety;

机译：并行化疗;结核病;乳腺癌;结直肠癌;疗效;胃癌;肺癌;安全性;

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of concurrent anti-Cancer and anti-tuberculosis chemotherapy in Cancer patients with active Mycobacterium tuberculosis: a retrospective study [J] . Tomonori Hirashima, Yoshitaka Tamura, Yuki Han, BMC Cancer . 2018,第1期

机译：同时抗癌和抗结核化疗在癌症患者中活性分枝杆菌患者的疗效和安全性：回顾性研究
2. Comparison of the clinical courses and chemotherapy outcomes in metastatic colorectal cancer patients with and without active Mycobacterium tuberculosis or Mycobacterium kansasii infection: a retrospective study [J] . Tomonori Hirashima, Takayuki Nagai, Hironori Shigeoka, BMC Cancer . 2014,第1期

机译：具有和不具有活动性结核分枝杆菌或堪萨斯分枝杆菌感染的转移性结直肠癌患者的临床历程和化疗结果的比较：一项回顾性研究
3. Efficacy and safety of cholecalciferol-augmented anti-tuberculosis therapy for treatment of na?ve patients with pulmonary tuberculosis: A randomized, controlled, clinical study [J] . Ahmad Farooq Alsayed Hasanain, Ali Abdel-Azeem Hasan Zayed, Rasha Bakheet Abd-ellatief, The Indian journal of tuberculosis. . 2019,第1期

机译：胆钙化固醇增强抗结核疗法治疗初治性肺结核的疗效和安全性：一项随机对照临床研究
4. Study on immunogenicity and protective efficacy of a new vaccine expressing Ag85B and MPT83 fusion protein from Mycobacterium tuberculosis [C] . Yufei Jin, Hong Bao, Jing Chang, International Conference on Human Health and Medical Engineering. . 2014

机译：从结核分枝杆菌中表达AG85B和MPT83融合蛋白的新疫苗免疫原性和保护效果的研究
5. Effective combination of syngeneic HCT with CRCL vaccination to treat BCR-ABL+ leukemia, and, CD4+CD25+FOXP3+ regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. [D] . Chen, Xinchun. 2006

机译：同基因HCT与CRCL疫苗的有效结合可治疗BCR-ABL +白血病，CD4 + CD25 + FOXP3 +调节性T细胞可抑制活动性疾病患者的结核分枝杆菌免疫力。
6. Efficacy and safety of concurrent anti-tuberculosis treatment and chemotherapy in lung cancer patients with co-existent tuberculosis [O] . Mei-Feng Ye, Shan Su, Zhi-Hao Huang, 2020

机译：同时抗结核治疗和化疗在肺癌患者与共存结核病患者的疗效和安全性
7. P1.01-13 Efficacy and Safety of Concurrent Anti-Tuberculosis Treatment and Chemotherapy in Lung Cancer Patients with Co-Existent Tuberculosis [O] . M. Ye, S. Su, W. Cen, 2019

机译：P1.01-13肺癌患者共存结核病患者同时抗结核治疗和化疗的疗效和安全性

Efficacy and safety of concurrent anti-Cancer and anti-tuberculosis chemotherapy in Cancer patients with active Mycobacterium tuberculosis: a retrospective study

摘要

著录项

相似文献

相关主题

期刊订阅